Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Doctoral Foreign Study Award (DFSA)

Direct Payment

$105,000.00

Identification of autoantigens using T cell traps

EF 2016-17

Résumé
Autoimmune disorders result from the targeted destruction of tissues by dysregulated immune cells. The specificity of this response is mediated by immune reactivity towards particular disease-promoting proteins, such as insulin in the case of type I diabetes. While targeted therapies have been developed to overcome issues of non-specificity associated with conventional treatments, their translation to the clinic has yet to gain traction. Part of the problem is that we do not know the identities of many of the disease-promoting proteins associated with autoimmune cells. Moreover, the scarcity of these cells in the blood and the inaccessibility of diseased tissues (where they are most prevalent) prevent their analysis. Thus, a strategy to enrich autoimmune cells would facilitate their study and the identification of disease-promoting proteins. Previously, we developed an implantable scaffold capable of "trapping" autoimmune cells; however, only a minor fraction of the trapped cells were autoimmune cells. Here, we aim to design an injectable material to improve trapping of autoimmune cells and identify their protein specificities. The material will be chemically or biologically modified to maximize enrichment of autoimmune cells and minimize inflammatory cell infiltration. We will evaluate the efficiency of autoimmune cell trapping using transgenic animal models and the specificity of the material system to trap autoimmune cells in the context of various autoimmune disease models. To identify the protein specificity of the trapped autoimmune cells, we will use single-cell sequencing and modified epitope prediction algorithms to predict, then validate potential disease-promoting proteins. This strategy will enable researchers to study autoimmune cell populations in various diseases and identify disease-promoting proteins. Knowledge of these proteins will facilitate the design and clinical translation of targeted medicines for treating autoimmune disease.
Programme
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
365410
Name
Zhang Kongyu
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Identification of autoantigens using T cell traps
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Keyworddelim
Antigen Discovery; Autoimmunity; Biomaterials; Immune Cell Traps
Abstract
Autoimmune disorders result from the targeted destruction of tissues by dysregulated immune cells. The specificity of this response is mediated by immune reactivity towards particular disease-promoting proteins, such as insulin in the case of type I diabetes. While targeted therapies have been developed to overcome issues of non-specificity associated with conventional treatments, their translation to the clinic has yet to gain traction. Part of the problem is that we do not know the identities of many of the disease-promoting proteins associated with autoimmune cells. Moreover, the scarcity of these cells in the blood and the inaccessibility of diseased tissues (where they are most prevalent) prevent their analysis. Thus, a strategy to enrich autoimmune cells would facilitate their study and the identification of disease-promoting proteins. Previously, we developed an implantable scaffold capable of "trapping" autoimmune cells; however, only a minor fraction of the trapped cells were autoimmune cells. Here, we aim to design an injectable material to improve trapping of autoimmune cells and identify their protein specificities. The material will be chemically or biologically modified to maximize enrichment of autoimmune cells and minimize inflammatory cell infiltration. We will evaluate the efficiency of autoimmune cell trapping using transgenic animal models and the specificity of the material system to trap autoimmune cells in the context of various autoimmune disease models. To identify the protein specificity of the trapped autoimmune cells, we will use single-cell sequencing and modified epitope prediction algorithms to predict, then validate potential disease-promoting proteins. This strategy will enable researchers to study autoimmune cell populations in various diseases and identify disease-promoting proteins. Knowledge of these proteins will facilitate the design and clinical translation of targeted medicines for treating autoimmune disease.
Competitiondate
201610
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Zhang, Kongyu
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~